Impact of cardiac magnetic resonance on the diagnosis of hypertrophic cardiomyopathy - a 10-year experience with over 1000 patients.
Mateusz ŚpiewakMariusz KłopotowskiNatalia OjrzyńskaJoanna Petryka-MazurkiewiczBarbara Miłosz-WieczorekŁukasz MazurkiewiczJacek GrzybowskiZofia BilińskaAdam WitkowskiMagdalena MarczakPublished in: European radiology (2020)
• Out of 550 patients previously diagnosed with echocardiography but without magnetic resonance imaging (MRI) as having hypertrophic cardiomyopathy (HCM), we diagnosed a different disease in 12 (2.2%) patients using MRI. • Among patients with suspected HCM based on echocardiography, MRI led to clear HCM diagnosis in 44.7% of patients. • In patients with a history of uncontrolled hypertension suspected, based on an echocardiogram, of having HCM, MRI aided in identifying cardiomyopathy in 47.9% of patients. This subgroup contained the largest proportion of patients with an ambiguous diagnosis.
Keyphrases
- hypertrophic cardiomyopathy
- magnetic resonance imaging
- end stage renal disease
- ejection fraction
- newly diagnosed
- left ventricular
- chronic kidney disease
- magnetic resonance
- prognostic factors
- blood pressure
- heart failure
- randomized controlled trial
- pulmonary hypertension
- clinical trial
- patient reported outcomes
- pulmonary embolism
- atrial fibrillation